Warning: file_put_contents(c/f0274477859d36aae918c9cb0533af72.php): Failed to open stream: No space left on device in /home/w/04uk/_____/f.php on line 239
Endolevicus Health Solutions Limited, CF10 4DW Company Information, Office Address, Contact, Directors & Officers, Accounts, Statements and Filing History : UKBizDB.co.uk
UKBizDB.co.uk

ENDOLEVICUS HEALTH SOLUTIONS LIMITED

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Endolevicus Health Solutions Limited. The company was founded 11 years ago and was given the registration number 08516642. The firm's registered office is in CARDIFF. You can find them at 5 Blake Court, Schooner Way, Cardiff, . This company's SIC code is 86900 - Other human health activities.

Company Information

Name:ENDOLEVICUS HEALTH SOLUTIONS LIMITED
Company Number:08516642
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:03 May 2013
Industry Codes:
  • 86900 - Other human health activities

Office Address & Contact

Registered Address:5 Blake Court, Schooner Way, Cardiff, CF10 4DW
Country Origin:
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
5, Blake Court, Schooner Way, Cardiff, United Kingdom, CF10 4DW

Director03 May 2013Active

People with Significant Control

Dr Ashish Kumar Paul
Notified on:06 April 2016
Status:Active
Date of birth:September 1956
Nationality:British
Country of residence:United Kingdom
Address:5 Blake Court, Schooner Way, Cardiff, United Kingdom, CF10 4DW
Nature of control:
  • Ownership of shares 75 to 100 percent

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (1 year ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (2 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (11 months ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (0 months remaining)

Copyright © 2024. All rights reserved.